US Patent 10081621 | Patents | Expiry | Expiration | Dates

VERTEX PHARMS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IVACAFTOR; IVACAFTOR, TEZACAFTOR

Supporting Information : Click here to upload a PDF

US Patent Number

10081621

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-03-25

Patent Use Code

U-2420

Delist Requested

Application Number

210491

Patent Use Description

Product Number

2

VERTEX PHARMS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IVACAFTOR; IVACAFTOR, TEZACAFTOR

Supporting Information : Click here to upload a PDF

US Patent Number

10081621

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-03-25

Patent Use Code

U-2420

Delist Requested

Application Number

210491

Patent Use Description

Product Number

1

VERTEX PHARMS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IVACAFTOR; IVACAFTOR, TEZACAFTOR

Supporting Information : Click here to upload a PDF

US Patent Number

10081621

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-03-25

Patent Use Code

U-2571

Delist Requested

Application Number

210491

Patent Use Description

Product Number

2

VERTEX PHARMS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

IVACAFTOR; IVACAFTOR, TEZACAFTOR

Supporting Information : Click here to upload a PDF

US Patent Number

10081621

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-03-25

Patent Use Code

U-2571

Delist Requested

Application Number

210491

Patent Use Description

Product Number

1

VERTEX PHARMS INC

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States Flag United States

Post An Enquiry

Virtual Booth

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

Supporting Information : Click here to upload a PDF

US Patent Number

10081621

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-03-25

Patent Use Code

U-2652

Delist Requested

Application Number

212273

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10081621

IVACAFTOR; IVACAFTOR, TEZACAFTOR

Y

2031-03-25

U-2420

2

IVACAFTOR; IVACAFTOR, TEZACAFTOR

Y

2031-03-25

U-2420

1

IVACAFTOR; IVACAFTOR, TEZACAFTOR

Y

2031-03-25

U-2571

2

IVACAFTOR; IVACAFTOR, TEZACAFTOR

Y

2031-03-25

U-2571

1

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

Y

2031-03-25

U-2652

1